Array
(
[id] => 3660152
[patent_doc_number] => 05624804
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-29
[patent_title] => 'Immunochemical detection of In vivo advanced glycosylation end products'
[patent_app_type] => 1
[patent_app_number] => 7/956849
[patent_app_country] => US
[patent_app_date] => 1992-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 13766
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/624/05624804.pdf
[firstpage_image] =>[orig_patent_app_number] => 956849
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/956849 | Immunochemical detection of In vivo advanced glycosylation end products | Sep 30, 1992 | Issued |
Array
(
[id] => 3111480
[patent_doc_number] => 05395750
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-03-07
[patent_title] => 'Methods for producing proteins which bind to predetermined antigens'
[patent_app_type] => 1
[patent_app_number] => 7/843125
[patent_app_country] => US
[patent_app_date] => 1992-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 26
[patent_no_of_words] => 7789
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/395/05395750.pdf
[firstpage_image] =>[orig_patent_app_number] => 843125
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/843125 | Methods for producing proteins which bind to predetermined antigens | Feb 27, 1992 | Issued |
Array
(
[id] => 2912227
[patent_doc_number] => 05227471
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-07-13
[patent_title] => 'Monoclonal antibody PD41 that binds to a prostate mucin antigen that is expressed in human prostatic carcinoma'
[patent_app_type] => 1
[patent_app_number] => 7/828057
[patent_app_country] => US
[patent_app_date] => 1992-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 12158
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/227/05227471.pdf
[firstpage_image] =>[orig_patent_app_number] => 828057
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/828057 | Monoclonal antibody PD41 that binds to a prostate mucin antigen that is expressed in human prostatic carcinoma | Jan 29, 1992 | Issued |